Resultats de la cerca - Shari Pilon‐Thomas
- Mostrar 1 - 20 resultats de 33
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer per Paul Toomey, Krithika N. Kodumudi, Amy Weber, Lisa Kühn, Ellen Moore, Amod A. Sarnaik, Shari Pilon‐Thomas
Publicat 2013Artigo -
7
-
8
-
9
-
10
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma per Tomar Ghansah, Nasreen A. Vohra, Kathleen Kinney, Amy Weber, Krithika N. Kodumudi, Gregory M. Springett, Amod A. Sarnaik, Shari Pilon‐Thomas
Publicat 2013Artigo -
11
Epigenetic reprogramming of tumor cell–intrinsic STING function sculpts antigenicity and T cell recognition of melanoma per Rana Falahat, Anders Berglund, Ryan M. Putney, Patricio Perez-Villarroel, Shota Aoyama, Shari Pilon‐Thomas, Glen N. Barber, James J. Mulé
Publicat 2021Artigo -
12
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy per Jessica Chacon, Richard C. Wu, Pariya Sukhumalchandra, Jeffrey J. Molldrem, Amod A. Sarnaik, Shari Pilon‐Thomas, Jeffrey S. Weber, Patrick Hwu, Laszlo Radvanyi
Publicat 2013Artigo -
13
Manipulating the Tumor Microenvironment <i>Ex Vivo</i> for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy per Jessica Chacon, Amod A. Sarnaik, Jie Qing Chen, Caitlin Creasy, Charuta Kale, John Robinson, Jeffrey S. Weber, Patrick Hwu, Shari Pilon‐Thomas, Laszlo Radvanyi
Publicat 2014Artigo -
14
-
15
-
16
Intralesional rose bengal in melanoma elicits tumor immunity<i>via</i>activation of dendritic cells by the release of high mobility group box 1 per Hao Liu, Patrick Innamarato, Krithika N. Kodumudi, Amy Weber, Satoshi Nemoto, John L. Robinson, Georgina Crago, Timothy McCardle, Erica Royster, Amod A. Sarnaik, Shari Pilon‐Thomas
Publicat 2016Artigo -
17
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy per Patrick Innamarato, Krithika N. Kodumudi, Sarah Asby, Benjamin Schachner, MacLean Hall, Amy Mackay, Doris Wiener, Matthew Beatty, Luz Nagle, Ben Creelan, Amod A. Sarnaik, Shari Pilon‐Thomas
Publicat 2020Artigo -
18
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy per Shari Pilon‐Thomas, Krithika N. Kodumudi, Asmaa El-Kenawi, Shonagh Russell, Amy Weber, Kimberly A. Luddy, Mehdi Damaghi, Jonathan W. Wojtkowiak, James J. Mulé, Arig Ibrahim‐Hashim, Robert J. Gillies
Publicat 2016Artigo -
19
Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma per Shari Pilon‐Thomas, Lisa Kühn, Sabine Ellwanger, William E. Janssen, Erica Royster, Suroosh S. Marzban, Ragini R. Kudchadkar, Jonathan S. Zager, Geoffrey T. Gibney, Vernon K. Sondak, Jeffrey S. Weber, James J. Mulé, Amod A. Sarnaik
Publicat 2012Artigo -
20
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma per Alexandra Pisklakova, Brienne McKenzie, Franz J. Zemp, Xueqing Lun, Rajappa S. Kenchappa, Arnold B. Etame, Masmudur M. Rahman, Karlyne M. Reilly, Shari Pilon‐Thomas, Grant McFadden, Ebba U. Kurz, Peter Forsyth
Publicat 2016Artigo
Eines de cerca:
Matèries relacionades
Cancer research
Immunology
Medicine
Biology
Immune system
Immunotherapy
Internal medicine
Cancer
Melanoma
T cell
Tumor-infiltrating lymphocytes
Genetics
Biochemistry
Adoptive cell transfer
CD8
Oncology
Pathology
Chemistry
Gene
In vitro
In vivo
Antigen
Biotechnology
Chemotherapy
Cytotoxic T cell
Cell
Cell biology
Computational biology
Cytokine
Environmental health